KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $202,000 | -36.9% | 1,123 | -63.6% | 0.00% | -50.0% |
| Q2 2017 | $320,000 | +65.8% | 3,086 | +25.5% | 0.00% | +100.0% |
| Q1 2017 | $193,000 | +192.4% | 2,459 | +65.7% | 0.00% | +100.0% |
| Q4 2016 | $66,000 | -1.5% | 1,484 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $67,000 | +21.8% | 1,200 | +9.1% | 0.00% | 0.0% |
| Q2 2016 | $55,000 | +34.1% | 1,100 | +22.2% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -16.3% | 900 | +12.5% | 0.00% | 0.0% |
| Q4 2015 | $49,000 | +28.9% | 800 | +18.5% | 0.00% | 0.0% |
| Q3 2015 | $38,000 | +533.3% | 675 | +575.0% | 0.00% | – |
| Q2 2015 | $6,000 | -57.1% | 100 | -59.5% | 0.00% | – |
| Q1 2015 | $14,000 | – | 247 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |